Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Erik W. Gunderson"'
Publikováno v:
PsychophysiologyREFERENCES. 59(10)
Positive social contact predicts better health, but the mechanisms for this association remain debated. One way to explore this link is through the social regulation of emotion, particularly anticipatory anxiety. Previous research finds less neural t
Publikováno v:
Drug and Alcohol Dependence. 178:534-543
Individuals who work nonstandard schedules, such as rotating or night shifts, are more susceptible to workplace injuries, performance decrements, and reduced productivity. This population is also almost twice as likely to use illicit drugs as individ
Autor:
Joanne B. Fertig, Eric Devine, Charles Scott, Gantt P. Galloway, Alan I. Green, Ihsan M. Salloum, Steven Shoptaw, Kyle M. Kampman, John Mendelson, Catherine Brooks, Kelly E. Dunn, Erik W. Gunderson, Nassima Ait-Daoud Tiouririne, Eric C. Strain, Raye Z. Litten, Heather Burns, Steven Caras, Lorenzo Leggio, Mary F. Brunette, Janet Ransom, Richard N. Rosenthal, Barbara J. Mason, Megan L. Ryan, Ricardo Cruz, Lara A. Ray, D. Jeffrey Newport, E. Sherwood Brown, Daniel E. Falk
Publikováno v:
Alcoholism: Clinical and Experimental Research.
BACKGROUND: Several single-site alcohol treatment clinical trials have demonstrated efficacy for immediate-release (IR) gabapentin in reducing drinking outcomes among individuals with alcohol dependence. The purpose of this study was to conduct a lar
Publikováno v:
Journal of Addictive Diseases. 35:325-338
This prospective, randomized, active-controlled, non-inferiority study evaluated the efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet (Zubsolv®; buprenorphine/naloxone rapidly dissolving tablet) versus generic bup
Autor:
Michael Sumner, Erik W. Gunderson
Publikováno v:
Journal of Addiction Medicine
Objectives: The aim of the study was to evaluate treatment retention, efficacy, and preference ratings among opioid-dependent patients transitioning between a buprenorphine/naloxone rapidly dissolving sublingual tablet formulation (BNX-RDT) and BNX f
Publikováno v:
Clinical Therapeutics. 37:2244-2255
Purpose Sublingual buprenorphine and combination buprenorphine/naloxone (BNX) are effective options for the treatment of opioid dependence. A BNX sublingual tablet approved by the US Food and Drug Administration for the induction and maintenance trea
Publikováno v:
Substance Abuse. 35:184-189
Background Despite growing concern about the increased rates of synthetic cannabinoid (SC) use and their effects, only limited data are available that addresses these issues. This study assessed the extent of SC product use and reported effects among
Publikováno v:
Journal of Addiction Medicine. 7:153-162
There is a growing concern about the availability of a new generation of "designer drug" stimulants that are marketed as "bath salts" and other household products. The products are not true bath salts and contain substituted cathinone stimulant subst
Publikováno v:
Journal of Addiction Medicine. 7:163-168
In this report, we describe a case of intranasal "bath salts"-associated psychosis. Symptoms developed during a 3-week binge and were potentially exacerbated by oral diphenhydramine taken for insomnia. The clinical case conference includes expert dis
Autor:
Lei Liu, Xin-Qun Wang, Heather M. Haughey, John D. Roache, Nassima Ait-Daoud, Bankole A. Johnson, Erik W. Gunderson
Publikováno v:
Addiction Biology. 18:405-416
Topiramate, presumably through antagonism of excitatory glutaminergic pathways and facilitation of inhibitory gamma-aminobutyric acid neurons in the cortico-mesolimbic system, might reduce cocaine’s abuse liability. We tested whether topiramate (10